Gordon, Kenneth B <br/><br/>
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Dec 2017 
 - 1030-1037 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Validation Study 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2017.08.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Dermatologic Agents--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Methotrexate--therapeutic use<br/>Models, Statistical<br/>Prognosis<br/>Psoriasis--drug therapy<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome